Clinical trial
The Effectiveness of Paracetamol Versus Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Neonates
NCT06601114 is registered in ClinicalTrials.gov with Arooj Khan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effectiveness of Paracetamol Versus Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Neonates
- Lead sponsor
- Arooj Khan
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 10, 2024
- Completion date
- October 10, 2024
- Enrollment
- 254 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
patent ductus arteriosus in preterm infants